BrainStorm Cell Therapeutics Inc. Engages Dr. Holly G. Atkinson

NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--April 25, 2006--BrainStorm Cell Therapeutics (OTCBB:BCLI - News) announced today that it has engaged Dr. Holly G. Atkinson, an experienced business executive and seasoned communications expert, to serve as the Company's Contract Director of Business Development. BrainStorm is developing stem cell therapeutic products for the treatment of neurodegenerative diseases.